Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Recent COVID-19 vaccination has been linked to a reduced risk of SARS-CoV-2 transmission in a prospective, case-ascertained household transmission study.

Recent COVID vaccination may reduce transmission

Tirzepatide lowers risk of diabetic retinopathy, complications

Treatment with tirzepatide, compared with lifestyle intervention alone, helps prevent the incidence of new or progressive diabetic retinopathy (DR) and its complications among patients with diabetes and overweight or obesity, suggests a study.

Tirzepatide lowers risk of diabetic retinopathy, complications

03 Jun 2026

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

In breast cancer patients with obesity or type 2 diabetes (T2D), the use of a glucagon-like peptide-1 receptor agonist (GLP-1 RA) appears to exert favourable effects on mortality and recurrence, according to a retrospective study.

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Researchers from the Chinese University of Hong Kong (CUHK) and the Gerald Choa Neuroscience Institute (GCNI) have achieved a breakthrough “bench-to-bedside” advancement, translating discovery of multi-omic ageing counteraction with glucagon-like peptide-1 (GLP-1) receptor agonism into a potential new treatment strategy for stroke.

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Researchers from the University of Hong Kong (HKU) have developed the world’s first NanoPowder nasal spray for use as prehospital emergency treatment at the onset of an ischaemic stroke, which can potentially reduce brain damage by >80 percent and substantially increase stroke survival rates and neurological recovery, representing a significant advancement in stroke management globally.

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Astegolimab gets mixed results in COPD

In the treatment of patients with chronic obstructive pulmonary disease (COPD), use of the anti-ST2 human IgG2 monoclonal antibody astegolimab every 2 weeks helps reduce the frequency of exacerbations compared with placebo in a phase 2b trial but not in a phase 3 trial.

Astegolimab gets mixed results in COPD

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

02 Jun 2026 bởi

Treatment with leflunomide in combination with hydroxychloroquine has been proven to be beneficial, helping reduce disease activity in patients with systemically active Sjögren’s disease, in the phase 2b RepurpSS-II trial.

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

02 Jun 2026 bởi

Treatment with corticosteroid-sparing topical interventions such as cyclosporine, tacrolimus, sodium cromoglycate, and interferon alpha-2 demonstrates efficacy in improving the signs and symptoms of vernal keratoconjunctivitis (VKC) in children, as shown in a study.

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

Olive leaf extract plus potassium may have cardiometabolic protective effect

The combination of olive leaf extract (OLE) and potassium appears to exert favourable effects on blood pressure (BP), lipid profile, oxidative status, and insulin sensitivity in individuals with mild to moderate BP elevation, according to a small study.

Olive leaf extract plus potassium may have cardiometabolic protective effect